Just caught up on HPP's latest earnings report and there's some interesting stuff here. The company's been navigating what looks like a pretty challenging real estate environment, especially with office space headwinds that seem to be hitting most REITs right now. HPP's portfolio has exposure to both office and life science properties, which gives them a bit more diversification than some peers I guess. Their recent quarter results show they're dealing with occupancy pressures and the whole commercial real estate slowdown that's been all over the news. What's worth watching with HPP is how they're managing through this cycle. The company's been making moves to reposition their portfolio, but it's clearly not an easy time for anyone in the REIT space. If you're looking at HPP from an investment angle, the key thing seems to be whether they can stabilize operations and find some tailwinds in the life science segment. The earnings transcript touches on their capital allocation strategy and how they're thinking about the next phase, but honestly HPP feels like one of those names where patience matters right now. The broader office REIT sector is under pressure, so it's not exactly a screaming buy moment, but the management commentary suggests they're at least being thoughtful about navigating the downturn.